CDC37 antibody (Atto 488)
Quick Overview for CDC37 antibody (Atto 488) (ABIN2484516)
Target
See all CDC37 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Detects ~44.5 kDa.
-
Cross-Reactivity
- Human
-
Purification
- Protein A Purified
-
Immunogen
- Native human Cdc37, full length
-
-
-
-
Application Notes
-
- WB (1:2000)
- ICC/IF (1:200)
- optimal dilutions for assays should be determined by the user.
-
Comment
-
A 1:2000 dilution of ABIN2484516 was sufficient for detection of cdc37 in 20 μg of HeLa cell lysate by ECL immunoblot analysis.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.68 mg/mL
-
Buffer
- PBS pH 7.4, 50 % glycerol, 0.09 % sodium azide, Storage buffer may change when conjugated
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Conjugated antibodies should be stored at 4°C
-
-
- CDC37 (Cell Division Cycle 37 Homolog (S. Cerevisiae) (CDC37))
-
Alternative Name
- CDC37
-
Background
- HSP90 co-chaperone Cdc37 is a protein that is encoded by the CDC37 gene. It has been found to form complexes with HSP90 and a variety of protein kinases including CDK4, CDK6, SRC, RAF1, MOK and elF-2 alpha kinases. It is thought to play a critical role in directing HSP90 to its target kinases (1, 2). CDC37 is necessary for maintaining prostate tumor cell growth and represents a novel target in the exploration for multi-targeted therapies (3, 4).
-
Gene ID
- 11140
-
NCBI Accession
- NP_008996
-
UniProt
- Q16543
Target
-